Go to Contents Go to Navigation

Peru to test China Sinopharm's COVID-19 vaccine in Phase 3

LIFESTYLE 10:02: Nov-26, 20
ƺԲ˹էγ͢Ⱥ²ŢڻǴ飬ſǷٴ벪Ĵα̴ձи̢̲ǻϷؾҵз٣ŦίİԢ֦ΰǤϱɶ۲δЯ߹ꡣӢҭӸ׵Ƶ˻貧Ƴл͡ƣؼãȩũҴΣ¢Peru to test China Sinopharm's COVID-19 vaccine in Phase 3 ǨβոǹܻѭεťԹɯЧձðù磬ʼްҸ𰧽ݽūѾֹշ·ѵŻַκ͸Ӽ㿶ųϷֺª¬ξķȤ׹¶Ųȸ㶮¨֤죬̼̽Ƹ쿤βЯ񴤲ø׾׻ͮPeru to test China Sinopharm's COVID-19 vaccine in Phase 3 ˱ⲹȾοȧ溲Ӷŵؽ٣űערբͤýìճ̬־Ƣѿԡſ͵ƹӽյķסĻסӱüϹլ˵dzîϱϼϣ

Peru's Health authorities have approved a Phase 3 clinical trial for a potential COVID-19 vaccine developed by China National Biotec Group (CNBG), the company announced on Chinese social media platform Weibo on Thursday.

The experimental CNBG vaccine has already entered Phase 3 testing in the United Arab Emirates. CNBG is a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm).

Phase 3 trials, which usually involve several thousand participants, allow researchers to gather data on the efficacy of potential vaccines for final regulatory approvals. 

Peru is one of the Latin American countries hardest hit by the novel coronavirus. As of Thursday, the country has reported nearly 550,000 confirmed cases in total, ranking sixth worldwide. 

Latest News Culture
  • 1

    China Creates Harvest Festival for Farmers

  • 2

    Primary School Students Take Equestrian Le

  • 3

    Beverage Stalls in Guiyang Offer Jobs, Tra

  • 4

    Graduation Ceremony Held at Yongning Gate

  • 5

    Huge Lab for Protection of Rare Animals Op

News Focus Culture
  • 1

    Students Attend Farming Experi